VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,743,695 | -35.5% | 1,678,207 | 0.0% | 2.82% | +2.3% |
| Q2 2023 | $39,924,545 | -6.5% | 1,678,207 | 0.0% | 2.76% | -7.0% |
| Q1 2023 | $42,693,586 | +86994.2% | 1,678,207 | 0.0% | 2.96% | -47.5% |
| Q4 2022 | $49,020 | -99.9% | 1,678,207 | +1.1% | 5.64% | +50.1% |
| Q3 2022 | $34,047,000 | +126.4% | 1,660,019 | +27.7% | 3.76% | +148.9% |
| Q2 2022 | $15,041,000 | -37.4% | 1,300,000 | 0.0% | 1.51% | -8.8% |
| Q1 2022 | $24,037,000 | -6.5% | 1,300,000 | 0.0% | 1.66% | +6.8% |
| Q4 2021 | $25,701,000 | +20.2% | 1,300,000 | 0.0% | 1.55% | +61.5% |
| Q3 2021 | $21,385,000 | – | 1,300,000 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |